Author:
ferreri CHRISTOPHERJAMES,afrough AIMAZ,dillard CHRISTENM.,patel KRINA
Reference60 articles.
1. Multiple myeloma;Palumbo;N Engl J Med,2011
2. Cancer statistics, 2021;Siegel;CA Cancer J Clin,2021
3. Treatment options for triple-class refractory multiple myeloma;Mikhael;Clin Lymphoma, Myeloma Leuk,2020
4. Oral selinexor–dexamethasone for triple-class refractory multiple myeloma;Chari;N Engl J Med,2019
5. Belantamab mafodotin for relapsed or refractory multiple myeloma (DREAMM-2): a two-arm, randomised, open-label, phase 2 study;Lonial;Lancet Oncol,2020